Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
27,470,929
-
Share change
-
+606,893
-
Total reported value
-
$491,180,341
-
Price per share
-
$17.88
-
Number of holders
-
82
-
Value change
-
+$4,753,957
-
Number of buys
-
43
-
Number of sells
-
28
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q3 2021
As of 30 Sep 2021,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,470,929 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock Inc., CANADA PENSION PLAN INVESTMENT BOARD, VANGUARD GROUP INC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., AMERIPRISE FINANCIAL INC, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/.
This page lists
82
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.